Xilio Therapeutics
31 hedge funds and large institutions have $33.5M invested in Xilio Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
5
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
KFI
26
Key Financial Inc
West Chester,
Pennsylvania
| $1.75K | 830 | – | – |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | 350 | -1,227 | -78% |
|
28
UBS Group
Zurich,
Switzerland
| $424 | 201 | – | – |
|
29
Wells Fargo
San Francisco,
California
| $211 | 100 | +19 | +23% |
|
|
CFB
30
Cullen/Frost Bankers
San Antonio,
Texas
| $211 | 100 | +100 | New |
|
31
Qube Research & Technologies (QRT)
London,
United Kingdom
| $8 | 4 | +4 | New |
|
32
Citadel Advisors
Miami,
Florida
| – | – | -13,149 | Closed |
|
33
Millennium Management
New York
| – | – | -12,894 | Closed |
|
|
NL
34
NWAM LLC
Mercer Island,
Washington
| – | – | -10,000 | Closed |
|
|
CFGS
35
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|